Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/14/16 → 4/14/19 |
Funding
- Covance Inc. (Prot #VX15-371-101 // Prot #VX15-371-101)
- Vertex Pharmaceuticals Incorporated (Prot #VX15-371-101 // Prot #VX15-371-101)
Prot #VX15-371-101: A Phase 2a, Randomized, Double-blind, Placebo-controlled, Incomplete Block, Crossover Study to Evaluate the Safety and Efficacy of VX-371 in Subjects Aged 12 Years or Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
- Jain, Manu (PD/PI)
- Lam, Anna P (Co-Investigator)
- Prickett, Michelle (Co-Investigator)
Project: Research project